Rosalind Advisors as of Sept. 30, 2025
Portfolio Holdings for Rosalind Advisors
Rosalind Advisors holds 39 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Delcath Sys Com New (DCTH) | 11.3 | $33M | 3.3M | 10.00 | |
| Cytokinetics Com New (CYTK) | 7.5 | $22M | 400k | 54.96 | |
| Fennec Pharmaceuticals (FENC) | 6.6 | $19M | 2.1M | 9.36 | |
| Verastem Com New (VSTM) | 5.8 | $17M | 1.9M | 8.83 | |
| Rezolute Com New (RZLT) | 5.8 | $17M | 1.8M | 9.40 | |
| Xeris Pharmaceuticals (XERS) | 5.0 | $15M | 1.8M | 8.14 | |
| Savara (SVRA) | 4.9 | $14M | 4.0M | 3.57 | |
| Mediwound Shs New (MDWD) | 4.6 | $14M | 749k | 18.02 | |
| Miragen Therapeutics (VRDN) | 4.4 | $13M | 600k | 21.58 | |
| Cg Oncology (CGON) | 4.1 | $12M | 300k | 40.28 | |
| Verona Pharma Sponsored Ads (VRNA) | 3.6 | $11M | 100k | 106.71 | |
| Ideaya Biosciences (IDYA) | 3.3 | $9.5M | 350k | 27.21 | |
| Inspiremd (NSPR) | 3.2 | $9.4M | 3.9M | 2.41 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 3.2 | $9.3M | 650k | 14.24 | |
| Mind Medicine Mindmed Com New (MNMD) | 3.0 | $8.8M | 750k | 11.79 | |
| Cybin Com New (CYBN) | 3.0 | $8.8M | 1.5M | 5.89 | |
| Fractyl Health (GUTS) | 2.7 | $8.0M | 5.0M | 1.59 | |
| Atyr Pharma Com New (ATYR) | 2.6 | $7.6M | 1.0M | 7.28 | |
| Uniqure Nv SHS (QURE) | 2.5 | $7.3M | 125k | 58.37 | |
| X4 Pharmaceuticals Com New (XFOR) | 1.8 | $5.3M | 1.5M | 3.42 | |
| Ocular Therapeutix (OCUL) | 1.6 | $4.7M | 400k | 11.69 | |
| Atyr Pharma Put Put Option | 1.5 | $4.5M | 1.6M | 2.85 | |
| Talphera Com New (TLPH) | 1.3 | $3.9M | 4.4M | 0.89 | |
| Profound Med Corp Com New (PROF) | 1.2 | $3.4M | 692k | 4.89 | |
| Myomo Com New (MYO) | 1.2 | $3.4M | 3.8M | 0.89 | |
| Polypid (PYPD) | 1.0 | $3.1M | 919k | 3.33 | |
| Invesco Qqq Tr Put Put Option | 0.5 | $1.6M | 250k | 6.23 | |
| Biofrontera Com New (BFRI) | 0.4 | $1.1M | 1.1M | 0.98 | |
| Astria Therapeutics (ATXS) | 0.4 | $1.1M | 1.5M | 0.72 | |
| Spdr Series Trust Put Put Option | 0.3 | $951k | 2.1M | 0.45 | |
| Trevi Therapeutics (TRVI) | 0.3 | $915k | 100k | 9.15 | |
| Verastem Call Call Option | 0.3 | $898k | 647k | 1.39 | |
| Kura Oncology (KURA) | 0.3 | $885k | 100k | 8.85 | |
| Spdr S&p 500 Etf Tr Put Put Option | 0.2 | $718k | 300k | 2.39 | |
| Rezolute Call Call Option | 0.2 | $546k | 263k | 2.08 | |
| Ideaya Biosciences Call Call Option | 0.1 | $237k | 36k | 6.60 | |
| Replimune Group Call Call Option | 0.1 | $183k | 511k | 0.36 | |
| Ishares Tr Put Put Option | 0.0 | $20k | 200k | 0.10 | |
| Scholar Rock Hldg Corp Put Put Option | 0.0 | $10k | 100k | 0.10 |
